Fusen Pharmaceutical Co (HKSE:01652) Total Assets : HK$1,439.7 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Fusen Pharmaceutical Co Total Assets?

Fusen Pharmaceutical Co's Total Assets for the quarter that ended in Jun. 2024 was HK$1,439.7 Mil.

Warning Sign:

If a company builds assets at 15.6% a year, faster than its revenue growth rate of 2.9% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Fusen Pharmaceutical Co's average Total Assets Growth Rate was 6.40% per year. During the past 3 years, the average Total Assets Growth Rate was 9.10% per year. During the past 5 years, the average Total Assets Growth Rate was 15.60% per year.

During the past 9 years, Fusen Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 27.50%. The lowest was -24.60%. And the median was 11.15%.

Total Assets is connected with ROA %. Fusen Pharmaceutical Co's annualized ROA % for the quarter that ended in Jun. 2024 was -5.47%. Total Assets is also linked to Revenue through Asset Turnover. Fusen Pharmaceutical Co's Asset Turnover for the quarter that ended in Jun. 2024 was 0.15.

Fusen Pharmaceutical Co Total Assets Historical Data

The historical data trend for Fusen Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusen Pharmaceutical Co Total Assets Chart

Fusen Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

1,308.85

1,471.53

1,517.53

1,507.86

1,469.76

Fusen Pharmaceutical Co Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Assets	Get a 7-Day Free Trial												1,428.86	1,507.86	1,435.48	1,469.76	1,439.74

Fusen Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Fusen Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	614.951	+	854.809
	=	1,469.8

Fusen Pharmaceutical Co's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	558.898	+	880.842
	=	1,439.7

Fusen Pharmaceutical Co (HKSE:01652) Total Assets Explanation

Total Assets is connected with ROA %.

Fusen Pharmaceutical Co's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	-79.538	/	( (1469.76	+	1439.74)	/ 2 )
	=	-79.538	/	1454.75
	=	-5.47 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Fusen Pharmaceutical Co's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	211.349	/	( (1469.76	+	1439.74)	/ 2 )
=	211.349	/	1454.75
=	0.15

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Fusen Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Fusen Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Fusen Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fusen Pharmaceutical Co Ltd (HKSE:01652) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

Urban Industrial Zone, Henan Province, Xichuan County, Zhengzhou, CHN

Website

http://www.fusenyy.com

Fusen Pharmaceutical Co Ltd is engaged in manufacturing shuanghuanglian based cold medicine. The product portfolio company includes shuanghuanglian based cold medicines which include oral solutions and shuanghuanglian injections, other PCM and western medicine products which include compound ferrous sulphate granules and flunarizine hydrochloride capsules.

Executives

Cao Changcheng	2201 Interest of corporation controlled by you
Quan Xiufeng	2202 Interest of your spouse
Full Bliss Holdings Limited	2101 Beneficial owner
One Victory Investments Limited	2101 Beneficial owner
Cao Zhiming	2201 Interest of corporation controlled by you
Zhou Peilin	2202 Interest of your spouse
Rayford Global Limited	2306 Nominee for another person
Tct (bvi) Limited	2501 Other
The Core Trust Company Limited	2301 Trustee
First Joint Elegant Limited	2101 Beneficial owner
Fung Wai Sze	2202 Interest of your spouse
Lam Yiu Por	2201 Interest of corporation controlled by you

Fusen Pharmaceutical Co Headlines

No Headlines